MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-16-0016733
Astra-Indo Pharma India Private Limited
Astra-Indo Pharma India Private Limited - e-commerce in Delhi, India. Directors, charges & compliance details.
Revenue · FY 2025
₹1.08 Cr
▲ 4% YoY
Net profit · FY 2025
₹5,825
Net margin 0.1%
EBITDA · FY 2025
₹2.54 Lakh
EBITDA margin 2.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹26 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Astra-Indo Pharma India Private Limited
Data last updated:
Astra-Indo Pharma India Private Limited is a private limited company based in Delhi, India. It operates in the online retail and e-commerce segment of the e-commerce sector. It was incorporated on 01 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52520DL2020PTC363124. Its GSTIN is 06AATCA4204A1Z5 (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Ujjwal Bansal and Shreya Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 240 1st Floor Kp Block Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.08 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹5,825 (net margin 0.1%) and EBITDA of ₹2.54 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.
As per MCA filings, the company has open charges of ₹26 Lakh on record. Court records list 7 cases involving the company, including 7 filed by the company; 6 cases are pending.
Astra-Indo Pharma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-16-0016733).
Company details
CIN U52520DL2020PTC363124
Registration Number 363124
Incorporation Date 01 April 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-16-0016733
Key People
Ujjwal Bansal Director Shreya Gupta Director Recognitions & Rankings of Astra-Indo Pharma India
Contact details
Astra-Indo Pharma India Private Limited's registered office is in Delhi, Delhi.
- Registered AddressHouse No 240 1st Floor Kp Block Pitampura, Delhi, India – 110034
- IndustryE-Commerce, Online Store, Retailers
Comprehensive company report
Astra-Indo Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Astra-Indo Pharma India is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Astra-Indo Pharma India Private Limited, buy the company report.
Financials of Astra-Indo Pharma India Private Limited
FY 2025 filings availableAstra-Indo Pharma India Private Limited reported revenue of ₹1.08 Cr (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹1.08 Cr ▲ 4%
Net profit · FY 2025
₹5,825 margin 0.1%
EBITDA · FY 2025
₹2.54 Lakh margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 53%
Revenue has grown at a compounded annual rate (CAGR) of 13% over three years, including 4% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,825 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astra-Indo Pharma India Private Limited, buy the company report.
Board of directors of Astra-Indo Pharma India Private Limited
Astra-Indo Pharma India has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ujjwal Bansal Also directs: Gecko Genie International Private Limited | Director | 01 Apr 2020 | 6 Years 6 Months | Current |
| Shreya Gupta | Director | 08 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Astra-Indo Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ojashvee Exim P.Ltd. | ₹1.08 Cr (FY 2024) | -23.0% | Mumbai, Maharashtra, India | |||
| G1astra Electromotive Private Limited | ₹1.08 Cr (FY 2025) | 20.0% | Delhi, India | |||
| Avaneesh Pharmaceuticals Private Limited | ₹1.08 Cr (FY 2025) | 567.0% | Jalgaon, Maharashtra, India | |||
| RGL Foods Private Limited | ₹1.08 Cr (FY 2025) | 4.0% | Bhusawal, Maharashtra, India | |||
| Leevacare Private Limited | ₹1.08 Cr (FY 2025) | 240.0% | Ambalappuzha, Kerala, India | |||
| Astra-Indo Pharma India Private Limitedthis company | ₹1.08 Cr (FY 2025) | ₹5,825 | 0.1% | 4.0% | Delhi, India | |
| Astramart Private Limited | ₹1.08 Cr (FY 2025) | 145.0% | Thavanampalle, Andhra Pradesh, India | |||
| Beautylia Cosmetics Private Limited | ₹1.07 Cr (FY 2025) | 302212.0% | Sonipat, Haryana, India | |||
| Techroom Technologies Private Limited | ₹1.07 Cr (FY 2025) | -44.0% | Noida, Uttar Pradesh, India | |||
| Ajaccio Private Limited | ₹1.07 Cr (FY 2024) | 82.0% | Thane, Maharashtra, India | |||
| Tradertree Private Limited | ₹1.07 Cr (FY 2025) | 31.0% | Delhi, India |
To see the full peer comparison of Astra-Indo Pharma India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹26 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jan 2022 | 100528869 | Others | ₹26 Lakh | Open |
To see the full charge records of Astra-Indo Pharma India Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Astra-Indo Pharma India Private Limited has 7 court cases on record: 7 filed by Astra-Indo Pharma India. 6 cases are pending and 1 is disposed.
Total cases
7
Filed by the company
7
Pending
6
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 0 | 6 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rohtak, Haryana | Cheque dishonour complaint | Filed by the company against individuals | Pending |
| District court, Rohtak, Haryana | Cheque dishonour complaint | Filed by the company against Hilarity Pharmaceuticals and 1 other | Pending |
| District court, Rohtak, Haryana | Cheque dishonour complaint | Filed by the company against Hari Aum Enterprises and 1 other | Pending |
| District court, Rohtak, Haryana | Cheque dishonour complaint | Filed by the company against individuals | Pending |
| District court, Rohtak, Haryana | Cheque dishonour complaint | Filed by the company against L R N Pharmaceutials, Through Its Proprietor Sumit | Pending |
To see the full case history of Astra-Indo Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Astra-Indo Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Astra-Indo Pharma India has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AATCA4204A1Z5 | Haryana | Active | 02 Apr 2021 |
To see the full GST registrations and return filing status of Astra-Indo Pharma India Private Limited, buy the company report.
Recent activity
Astra-Indo Pharma India Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Shreya Gupta was appointed as Director on 08 Aug 2024.
AGM
Astra-Indo Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Astra-Indo Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Shreya Gupta was appointed as Director.
Charges
A charge with Others of Rs. 26.00 Lakh registered on 18 Jan 2022 with Charge ID 100528869 was modified on 12 Mar 2023.
Charges
A charge with Others amounted to Rs. 26.00 Lakh with Charge ID 100528869 was registered on 18 Jan 2022.
Ceased
Sangeeta Bansal ceased to be Additional Director.
Ceased
Sanjay Wadhwa ceased to be Director.
Ceased
Umesh Kansal ceased to be Director.
Appointed
Ujjwal Bansal was appointed as Director.
Incorporation
01 Apr 2020
Astra-Indo Pharma India Private Limited was registered on 01 Apr 2020 with Roc Delhi Ii & aged 6 years 6 months as per MCA records.
Frequently asked questions
Astra-Indo Pharma India is an active private limited company based in Delhi, India. The company works in online store, within the e-commerce industry. It was incorporated on 01 April 2020 (6+ years old) and is registered under CIN U52520DL2020PTC363124.
Astra-Indo Pharma India has 2 current directors:
- Ujjwal Bansal - Director
- Shreya Gupta - Director
The latest financial statements of Astra-Indo Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Astra-Indo Pharma India is 06AATCA4204A1Z5, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Astra-Indo Pharma India is U52520DL2020PTC363124. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astra-Indo Pharma India has 7 court cases on record: 7 filed by the company. 6 are pending.
Astra-Indo Pharma India was incorporated on 01 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Astra-Indo Pharma India by revenue are Ojashvee Exim P.Ltd, G1astra Electromotive Private Limited, Avaneesh Pharmaceuticals Private Limited, RGL Foods Private Limited, Leevacare Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Shreya Gupta was appointed as Director on 08 Aug 2024. Sangeeta Bansal ceased to be Additional Director on 16 Nov 2021. Sanjay Wadhwa ceased to be Director on 11 Sep 2021. Astra-Indo Pharma India has 5 board changes on record in total.
Yes, Astra-Indo Pharma India is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-16-0016733).
The registered office of Astra-Indo Pharma India is at House No 240 1st Floor Kp Block Pitampura, Delhi, India – 110034.